| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $2.1M | -43.5% |
| SG&A Expense | $6.9M | +255.8% |
| Operating Income | -$9.1M | -5.8% |
| Interest Expense | $45K | -54.2% |
| Net Income | -$9.2M | -0.6% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.9M | +6357.1% |
| Current Assets | $9.0M | +5239.2% |
| Total Assets | $9.0M | +3983.1% |
| Current Liabilities | $2.9M | -74.1% |
| Total Liabilities | $2.9M | -74.4% |
| Stockholders' Equity | $6.0M | +153.4% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.8M | -162.8% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $15.6M | +554.0% |